Press Releases

ORANGE COUNTY, Calif., Oct. 2, 2019 /PRNewswire/ -- WebFitness, a live online interactive workout, is now being used in upscale apartment complexes as a new resource for their residents.  Apartment complex owners, who are looking for a way to differentiate properties in the marketplace, are upgrading their facilities by including WebFitness in their workout ro

SAN FRANCISCO, Oct. 2, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing of a $50 million senior secured debt facility with investment affiliates managed by Solar Capital Partners, LLC.

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/--- Initial tranche includes US$10 million subscription from Canopy Rivers. TORONTO, Oct. 2, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend

SOUTH SAN FRANCISCO, Oct. 2, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has entered into a $60 million term loan credit facility with MidCap Financial ("MidCap"). At closing, $10 million was funded to Rigel in an initial tranche. The facility also give

REDWOOD CITY, Calif., Oct. 2, 2019 /PRNewswire/ -- Karius, a life sciences company that uses metagenomics to rapidly detect over 1,400 pathogens using a simple blood draw, announced new findings that demonstrate the clinical utility of its Karius Test to detect pathogens causing serious infections including those diseases that are difficult to diagnose through conventio

ANNAPOLIS, Md., Oct. 2, 2019 /PRNewswire/ -- Vision Innovation Partners is pleased to announce its acquisition of Metropolitan Ophthalmology Associates, a leading ophthalmology practice with locations in Chevy Chase, Maryland and McLean, Virginia. The acquisition further expands Vision Innovation Partners

LONDON, Oct. 2, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce new positive data in the Company's ongoing Phase 1/2a clinical trial of its human retinal progenitor cell (hRPC) therapy candidate in the blindness-causing disease, retinitis pigmentosa (RP).  At most

FREIBERG, Germany, Oct. 2, 2019 /PRNewswire/ -- Bruker (Nasdaq: BRKR) today announced the acquisition of the Magnettech EPR business from Freiberg Instruments GmbH, and the establishment of a related, long-term EPR supply partnership with Freiberg Instruments.  Financial details of the transaction were not disclosed. 

NEW YORK and LONDON, Oct. 2, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseas

PROVIDENCE, R.I., Oct. 2, 2019 /PRNewswire/ -- Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation.  Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Ma